KMgCit Superior to KCl for Preventing Thiazide-Induced Hyperglycemia
By Elana Gotkine HealthDay Reporter
TUESDAY, Dec. 26, 2023 -- For patients with hypertension without diabetes, potassium magnesium citrate (KMgCit) is better than potassium chloride (KCl) for preventing thiazide diuretic (TD)-induced hyperglycemia, according to a study published in the December issue of Hypertension.
Noting that TDs, which are the first-line treatment for hypertension, can cause excess risk for diabetes, Wanpen Vongpatanasin, M.D., from the University of Texas Southwestern Medical Center in Dallas, and colleagues conducted a double-blinded randomized clinical trial involving 60 patients with hypertension (without diabetes) to compare the effects of 16 weeks of KCl to KMgCit during chlorthalidone treatment. Before randomization, each patient received chlorthalidone alone for three weeks.
The researchers found that chlorthalidone alone induced a significant increase in fasting plasma glucose and significant decreases in serum K, serum Mg, and 24-hour urinary citrate excretion. The rise in fasting plasma glucose was attenuated by 7.9 mg/dL with KMgCit versus KCl. No significant differences were seen between the groups in liver fat.
"These findings suggest that KMgCit may offer a superior alternative to KCl, typically used in clinical practice, in maintaining serum potassium during thiazide-diuretic treatment while avoiding thiazide-induced hyperglycemia," the authors write.
Three authors hold a patent for KMgCit.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted December 2023
Read this next
Blood Pressure Down With Self-Monitoring of BP, Self-Titration of Medications
FRIDAY, May 10, 2024 -- Blood pressure (BP) self-monitoring, together with self-titration of antihypertensive medications, is associated with a reduction in BP, according to a...
Novel Genetic Loci ID'd for Hypertension in European Ancestry
TUESDAY, May 7, 2024 -- A total of 113 novel genetic loci have been identified in the largest single-stage common variant genome-wide association study of blood pressure (BP)...
Long-Term Risk for MACE Increased for Children With Hypertension
TUESDAY, May 7, 2024 -- The long-term risk for major adverse cardiac events (MACE) is increased for children diagnosed with hypertension, according to a study published online May...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.